GOLDMAN MYLA LAI

CIK 1168581 · EVP & Chief Medical Officer · last filed 2026-05-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$6.82M

Companies

5

Total Filings

62

Lifetime Open-Market Net

-$6.85M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
WSTw Director 20,434 $0 25 2026-05-06
QTRX Director 54,804 $3.10 $169.9K $0 3 2026-01-06
Akoya Biosciences, Inc. (AKYA) Delisted Director 20,000 $1.29 $25.8K $100.0K 5 2024-06-05
SEQUENOM INC (SQNM) Delisted Director 0 $18.4K 10 2016-09-07
LH EVP & Chief Medical Officer 24,990 $266.16 $6.65M -$6.97M 18 2008-11-24

Recent Filings · Page 2 of 7

62 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-04-27 WSTw Grant (A) +616 $0 EDGAR
2022-06-03 Akoya Biosciences, Inc. (AKYA) Delisted Grant (A) $0 EDGAR
2022-05-26 WSTw Grant (A) +632 $0 EDGAR
2021-09-20 Akoya Biosciences, Inc. (AKYA) Delisted Grant (A) $0 EDGAR
2021-05-06 WSTw Grant (A) +577 $0 EDGAR
2020-05-07 WSTw Grant (A) +975 $0 EDGAR
2019-05-09 WSTw Grant (A) +1,565 $0 EDGAR
2018-08-01 WSTw Grant (A) $0 EDGAR
2018-05-03 WSTw Grant (A) +1,824 $0 EDGAR
2017-10-03 WSTw Grant (A) $0 EDGAR
Showing 1120 of 62
Page 2 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.